Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms. ✅
Go to Publication ✅
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi (J Microbiol Immunol Infect ) Vol: 50 Issue 6 Pages: 879-885 Pub: 2017 Dec Epub: 2016 Dec 18 Authors Chiu CC , Lin TC , Wu RX , Yang YS , Hsiao PJ , Lee Y , Lin JC , Chang FY , |
|
|
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)]. ✅
The Japanese journal of antibiotics (Jpn J Antibiot ) Vol: 51 Issue 7 Pages: 437-74 Pub: 1998 Jul Epub: Authors Ikemoto H , Watanabe K , Mori T , Igari J , Oguri T , Shimizu Y , Terai T , Inoue H , Nakadate T , Ito C , Yoshida T , Ohno I , Tanno Y , Arakawa M , Igarashi K , Okada M , Ozaki K , Aoki N , Kitamura N , Sekine O , Suzuki Y , Nakata K , Nakatani T , Inagawa H , Kusano N , |
|
|
Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients. ✅
Diagnostic microbiology and infectious disease (Diagn Microbiol Infect Dis ) Vol: 47 Issue 3 Pages: 527-37 Pub: 2003 Nov Epub: Authors Casellas JM , Tomé G , Bantar C , Bertolini P , Blázquez N , Borda N , Couto E , Cudmani N , Guerrera J , Juárez MJ , López T , Littvik A , Méndez E , Notario R , Ponce G , Quinteros M , Salamone F , Sparo M , Sutich E , Vaylet S , Wolff L , |
|
|
[Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study]. ✅
Mikrobiyoloji bulteni (Mikrobiyol Bul ) Vol: 48 Issue 4 Pages: 523-37 Pub: 2014 Oct Epub: Authors Atmaca O , Zarakolu P , Karahan C , Cakir B , Unal S , |
|
|
Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme. ✅
The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 53 Issue 6 Pages: 1018-32 Pub: 2004 Jun Epub: 2004 May 5 Authors Reynolds R , Potz N , Colman M , Williams A , Livermore D , MacGowan A , BSAC Extended Working Party on Bacteraemia Resistance Surveillance. , |
|
|
Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program. ✅
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases (Braz J Infect Dis ) Vol: 4 Issue 5 Pages: 236-44 Pub: 2000 Oct Epub: Authors Mendes C , Hsiung A , Kiffer C , Oplustil C , Sinto S , Mimica I , Zoccoli C , Mystic Study Group. , |
|
|
Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002). ✅
Annals of clinical microbiology and antimicrobials (Ann Clin Microbiol Antimicrob ) Vol: 3 Issue Pages: 14 Pub: 2004 Jul 29 Epub: 2004 Jul 29 Authors Jones ME , Draghi DC , Thornsberry C , Karlowsky JA , Sahm DF , Wenzel RP , |
|
|
The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia. ✅
The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 31 Suppl A Issue Pages: 97-104 Pub: 1993 Jan Epub: Authors Wise R , |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.